Latest Breaking News On - Digitalis ventures - Page 2 : comparemela.com

Elegen Raises $35M in Series B Funding

Elegen Raises $35M in Series B Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Matthew hillPeter zhouJohn ballantyneAndreessen horowitzAgilent technologiesSan carlosTriatomic capitalKdt venturesDigitalis venturesAlix venturesGeneral partner

Alterome Therapeutics Raises $132M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesEric murphyAlterome therapeuticsGoldman sachs alternativesCanaan partnersDriehaus capital managementDigitalis venturesBlue owl capitalNextech investVida venturesBoxer capital

AACR 2024: EpiBiologics Advances Degraders of Membrane-Bound Proteins

AACR 2024: EpiBiologics Advances Degraders of Membrane-Bound Proteins
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesAnn lee karlonShyra gardaiJim wellsUniversity of californiaGetty images plusAltos labsSan mateoMubadala capitalPolaris partnersVivo capitalDigitalis venturesTaiho venturesEpibiologics chief scientific

Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives

Proceeds support advancement of two next-generation precision oncology programs into clinical development within 12 monthsFinancing led by Goldman Sachs Alternatives with participation by Canaan Partners, Driehaus Capital Management, Invus, Digitalis Ventures, Blue Owl Capital, and existing investorsSAN DI.

Josh richardsonUwe schoenbeckEric murphyAlterome therapeutics incLife sciences investing at goldman sachs alternativesGoldman sachsGoldman sachs alternativesCanaan partnersDriehaus capital managementDigitalis venturesBlue owl capitalAlterome therapeuticsNextech investVida venturesBoxer capitalManaging director

Alterome Therapeutics secures $132m in Series B funding

Alterome Therapeutics, a biopharmaceutical company, has closed a $132m Series B financing round.

Josh richardsonUwe schoenbeckEric murphyLife sciences investing at goldman sachs alternativesGoldman sachsGoldman sachs alternativesCanaan partnersDriehaus capital managementDigitalis venturesBlue owl capitalNextech investVida venturesBoxer capitalLife sciences investingSciences investing